Why differentiate low molecular weight heparins for venous thromboembolism?
about
Why differentiate low molecular weight heparins for venous thromboembolism?
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Why differentiate low molecular weight heparins for venous thromboembolism?
@ast
Why differentiate low molecular weight heparins for venous thromboembolism?
@en
Why differentiate low molecular weight heparins for venous thromboembolism?
@nl
type
label
Why differentiate low molecular weight heparins for venous thromboembolism?
@ast
Why differentiate low molecular weight heparins for venous thromboembolism?
@en
Why differentiate low molecular weight heparins for venous thromboembolism?
@nl
prefLabel
Why differentiate low molecular weight heparins for venous thromboembolism?
@ast
Why differentiate low molecular weight heparins for venous thromboembolism?
@en
Why differentiate low molecular weight heparins for venous thromboembolism?
@nl
P2860
P356
P1433
P1476
Why differentiate low molecular weight heparins for venous thromboembolism?
@en
P2093
Jawed Fareed
Jeanine M Walenga
P2860
P2888
P356
10.1186/1477-9560-5-8
P407
P577
2007-06-19T00:00:00Z
P5875
P6179
1025899776